ZipLine® Medical is commercializing a unique and potentially disruptive platform technology to address skin closure for a broad spectrum of applications ranging from surgical incisions used for procedures such as C-section, spine, orthopaedic and electrophysiology, to lacerations, laparoscopic port closure and skin excision.
For further information please contact us at info@ZipLineMedical.com.
China Materialia started in 2010 as an Open Innovation (OI) advisory company. Over the years, they have worked with many multinational companies to build open innovation network in China, including research institutions, start-up companies, incubators and accelerators.
Their foremost goal is to assist entrepreneurs in the making of great companies.
Claremont Creek Ventures (CCV) is a seed and early stage venture firm. CCV invests in digital healthcare, energy technology, payments/commerce, and online businesses. Working with the firm’s portfolio companies, CCV uses capital efficiently, stays lean and develops great teams. Utilizing the firm’s proprietary life-cycle venturing program, Claremont Creek Ventures also partners with entrepreneurs and institutions, including UC Berkeley, Lawrence Livermore Labs, Stanford University and UC Davis. Claremont Creek has more than $300 million in capital under management in two funds. CCV’s digital healthcare investments in addition to ZipLine include AssureRX, Cellscope, Fluxion Biosciences, Natera and Tibion. For more information, please contact: www.claremontcreek.com.
HighCape Partners is a growth equity fund that invests in commercial-stage life sciences companies. The firm applies decades of combined investment and operational experience to transform its portfolio companies into sustainable businesses with multiple exit alternatives.
MVM was founded in 1997 and manages several funds. MVM’s latest fund totals more than $700 million. MVM has a global perspective on healthcare and maintains offices in Boston and London.
MVM invests broadly across the healthcare sector, including biotechnology, specialty pharmaceuticals, medical technology, diagnostics, life science tools, consumer healthcare, veterinary medicine, healthcare services, and digital health.
Founded in 2006 as one of the pioneers of the new venture industry, XSeed Capital works with entrepreneurs to build differentiated technology startups that dramatically change markets. XSeed is comprised of serial entrepreneurs who appreciate the dedication, passion, anxiety and sleepless nights it takes to build something valuable from scratch.
With $110 million under management, XSeed makes initial investment commitments at the seed stage and continues to support its portfolio companies through multiple investment rounds. The XSeed team provides more than capital: they work hard to support their entrepreneurs. For more information, please contact: www.xseedcap.com.